J.P. Morgan Private Wealth Advisors’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-32,637
| Closed | -$111K | – | 1640 |
|
|
2018
Q3 | $111K | Buy |
32,637
+2,109
| +7% | +$7.17K | ﹤0.01% | 1523 |
|
|
2018
Q2 | $115K | Buy |
30,528
+5,908
| +24% | +$22.3K | ﹤0.01% | 1412 |
|
|
2018
Q1 | $100K | Buy |
24,620
+433
| +2% | +$1.76K | ﹤0.01% | 1217 |
|
|
2017
Q4 | $113K | Sell |
24,187
-466
| -2% | -$2.18K | ﹤0.01% | 1225 |
|
|
2017
Q3 | $175K | Buy |
24,653
+2,821
| +13% | +$20K | ﹤0.01% | 1169 |
|
|
2017
Q2 | $158K | Buy |
21,832
+5,252
| +32% | +$38K | ﹤0.01% | 1169 |
|
|
2017
Q1 | $102K | Buy |
+16,580
| New | +$102K | ﹤0.01% | 1290 |
|